We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
-17.44%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$1.3B
AUM Growth
-$316M
Cap. Flow
+$6.21M
Cap. Flow %
0.48%
Top 10 Hldgs %
44.12%
Holding
106
New
6
Increased
50
Reduced
21
Closed
6

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$48.7M
2
DG icon
Dollar General
DG
+$17.3M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$14.8M
4
TT icon
Trane Technologies
TT
+$14M
5
DAR icon
Darling Ingredients
DAR
+$11.5M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$31.8M
2
AME icon
Ametek
AME
+$30.7M
3
EXPE icon
Expedia Group
EXPE
+$24.7M
4
GPN icon
Global Payments
GPN
+$16.2M
5
PLD icon
Prologis
PLD
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 29.61%
2 Healthcare 19.34%
3 Consumer Discretionary 10.19%
4 Financials 9.73%
5 Industrials 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROP icon
26
Roper Technologies
ROP
$36.3B
$14M 1.07%
35,380
-585
-2% -$254K
BMY icon
27
Bristol-Myers Squibb
BMY
$127B
$13.2M 1.02%
171,794
+33,684
+24% +$2.57M
CRM icon
28
Salesforce
CRM
$134B
$12.6M 0.97%
76,053
-31,987
-30% -$5.65M
HZNP
29
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$12.4M 0.96%
+155,757
New +$14.8M
DXCM icon
30
DexCom
DXCM
$27.6B
$12.3M 0.94%
164,420
+2,916
+2% +$266K
ABT icon
31
Abbott
ABT
$180B
$11.3M 0.87%
104,185
+18,691
+22% +$2.12M
IOVA icon
32
Iovance Biotherapeutics
IOVA
$2.23B
$11.2M 0.86%
1,010,809
+483,393
+92% +$6.33M
AVGO icon
33
Broadcom
AVGO
$1.82T
$11.1M 0.85%
228,210
+10,970
+5% +$616K
BALL icon
34
Ball Corp
BALL
$17B
$11M 0.84%
159,562
-95,897
-38% -$7.28M
ADPT icon
35
Adaptive Biotechnologies
ADPT
$3.56B
$10.8M 0.83%
1,329,268
+569,856
+75% +$5.01M
AMT icon
36
American Tower
AMT
$77.7B
$10.2M 0.79%
40,000
– –
CI icon
37
Cigna
CI
$76.6B
$9.79M 0.75%
37,159
+1,929
+5% +$497K
CB icon
38
Chubb
CB
$140B
$9.74M 0.75%
49,551
+2,718
+6% +$560K
MUSA icon
39
Murphy USA
MUSA
$11.3B
$9.64M 0.74%
41,413
-500
-1% -$118K
BDX icon
40
Becton Dickinson
BDX
$43.1B
$8.79M 0.68%
35,661
+17,168
+93% +$4.36M
CRWD icon
41
CrowdStrike
CRWD
$187B
$8.45M 0.65%
200,624
+8,604
+4% +$390K
GH icon
42
Guardant Health
GH
$19.5B
$8.44M 0.65%
209,094
+3,894
+2% +$193K
AMP icon
43
Ameriprise Financial
AMP
$46.8B
$8.14M 0.63%
34,233
+2,823
+9% +$756K
PH icon
44
Parker-Hannifin
PH
$125B
$8.06M 0.62%
32,770
– –
ACN icon
45
Accenture
ACN
$89.9B
$7.99M 0.61%
+28,786
New +$8.65M
PSX icon
46
Phillips 66
PSX
$82.9B
$7.92M 0.61%
96,641
+5,199
+6% +$481K
BAC icon
47
Bank of America
BAC
$435B
$7.92M 0.61%
254,259
+14,782
+6% +$532K
MUR icon
48
Murphy Oil
MUR
$5.58B
$7.89M 0.61%
261,455
-15,000
-5% -$578K
NEE icon
49
NextEra Energy
NEE
$187B
$7.18M 0.55%
92,752
+5,334
+6% +$406K
ICE icon
50
Intercontinental Exchange
ICE
$82.4B
$7.1M 0.55%
75,475
+4,139
+6% +$442K
1
2
3 4 5

Similar funds

SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Aristotle Atlantic Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Aristotle Atlantic Partners held 106 positions worth $1.3B, down 20% from $1.62B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Aristotle Atlantic Partners's Q2 2022 filing shows 6 new, 50 increased, 21 reduced and 6 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 155,757 shares worth $12.4M. The largest sale was Adobe, an estimated $31.8M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aristotle Atlantic Partners's largest Q2 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 155,757 shares worth $12.4M.
  • Aristotle Atlantic Partners added most to Apple in Q2 2022, an estimated $48.7M increase.
  • Aristotle Atlantic Partners's biggest Q2 2022 reduction was Adobe, cutting an estimated $31.8M.
  • Aristotle Atlantic Partners fully exited Fidelity National Information Services in Q2 2022, selling an estimated $7.5M.
  • Aristotle Atlantic Partners's ten largest holdings make up 44% of its $1.3B portfolio in Q2 2022.
  • Aristotle Atlantic Partners opened 6 new positions and closed 6 in Q2 2022.
  • Aristotle Atlantic Partners's portfolio value fell 20% quarter-over-quarter to $1.3B.

Based on Aristotle Atlantic Partners's 13F filing for Q2 2022, filed 15 Aug 2022.